Nonviral methods for siRNA delivery
Open accessAbstract
RNA interference (RNAi) as a mechanism to selectively degrade mRNA (mRNA) expression has emerged as a potential novel approach for drug target validation and the study of functional genomics. Small interfering RNAs (siRNA) therapeutics has developed rapidly and already there are clinical trials ongoing or planned. Although other challenges remain, delivery strategies for siRNA become the main hurdle that must be resolved prior to the full-scale clinical development of siRNA therapeutics. This review provides an overview of the current delivery strategies for synthetic siRNA, focusing on the targeted, self-assembled nanoparticles which show potential to become a useful and efficient tool in cancer therapy.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Viral vectors are an efficient tool for gene transfection and account for many gene-therapy clinical trials.
“Viral vectors are a type of efficient tool for gene transfection and account for many gene-therapy clinical trials.[20, 25, 26]”
From RNA delivery biomaterials for the treatment of genetic and rare diseases (2019) · cites this paper as [25]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
2 retracted
Tolentino, M. J., Brucker, A. J., Fosnot, J., Ying, G., WU, I.-H., Malik, G., Wan, S., & Reich, S. J. (2004) · Retina · doi:10.1097/00006982-200402000-00018 · Cited by 173 · see citing works
RetractedTolentino, M. J., Brucker, A. J., Fosnot, J., Ying, G., Wu, I., Malik, G., Wan, S., & Reich, S. J. (2004) · Retina · doi:10.1097/00006982-200408000-00039 · Cited by 31 · see citing works
RetractedPotent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans
Fire, A., Xu, S., Montgomery, M. K., Kostas, S. A., Driver, S. E., & Mello, C. C. (1998) · Nature · doi:10.1038/35888 · Cited by 15,429 · see citing works
Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs
Soutschek, J., Akinc, A., Bramlage, B., Charissé, K., Constien, R., Donoghue, M., Elbashir, S. M., Geick, A., Hadwiger, P., Harborth, J., et al. (2004) · Nature · doi:10.1038/nature03121 · Cited by 2,189 · see citing works
Single-stranded antisense siRNAs guide target RNA cleavage in RNAi.
Martı̂nez, J., Patkaniowska, A., Urlaub, H., Lührmann, R., & Tuschl, T. (2002) · Cell · doi:10.1016/s0092-8674(02)00908-x · Cited by 1,550 · see citing works
RNAi-mediated gene silencing in non-human primates
Zimmermann, T. S., Lee, A. C. H., Akinc, A., Bramlage, B., Bumcrot, D., Fedoruk, M. N., Harborth, J., Heyes, J. A., Jeffs, L. B., John, M., et al. (2006) · Nature · doi:10.1038/nature04688 · Cited by 1,357 · see citing works
Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA
Judge, A. D., Sood, V., Shaw, J. R., Fang, D., McClintock, K., & MacLachlan, I. (2005) · Nature Biotechnology · doi:10.1038/nbt1081 · Cited by 1,250 · see citing works
Transvascular delivery of small interfering RNA to the central nervous system
Kumar, P., Wu, H., McBride, J. L., Jung, K.-E., Hee Kim, M., Davidson, B. L., Kyung Lee, S., Shankar, P., & Manjunath, N. (2007) · Nature · doi:10.1038/nature05901 · Cited by 1,246 · see citing works
Interfering with disease: a progress report on siRNA-based therapeutics
de Fougerolles, A., Vornlocher, H., Maraganore, J. M., & Lieberman, J. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2310 · Cited by 1,202 · see citing works
Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs
Morrissey, D. V., Lockridge, J. A., Shaw, L., Blanchard, K. S., Jensen, K., Breen, W., Hartsough, K. C., Machemer, L., Radka, S. F., Jadhav, V., et al. (2005) · Nature Biotechnology · doi:10.1038/nbt1122 · Cited by 1,168 · see citing works
Mechanism of DNA Release from Cationic Liposome/DNA Complexes Used in Cell Transfection,
Xu, Y., & Szoka, F. C. (1996) · Biochemistry · doi:10.1021/bi9602019 · Cited by 1,136 · see citing works
RNA interference targeting Fas protects mice from fulminant hepatitis
Song, E., Lee, S., Wang, J., Ince, M. N., Ouyang, N., Min, J., Chen, J., Shankar, P., & Lieberman, J. (2003) · Nature Medicine · doi:10.1038/nm828 · Cited by 1,112 · see citing works
RNAi therapeutics: a potential new class of pharmaceutical drugs
Bumcrot, D. A., Manoharan, M., Koteliansky, V., & Sah, D. W. Y. (2006) · Nature Chemical Biology · doi:10.1038/nchembio839 · Cited by 1,086 · see citing works
Strategies for silencing human disease using RNA interference
Kim, D. H., & Rossi, J. J. (2007) · Nature Reviews Genetics · doi:10.1038/nrg2006 · Cited by 1,078 · see citing works
Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors
Song, E., Zhu, P., Lee, S., Chowdhury, D., Kussman, S., Dykxhoorn, D. M., Feng, Y., Palliser, D., Weiner, D. B., Shankar, P., et al. (2005) · Nature Biotechnology · doi:10.1038/nbt1101 · Cited by 1,022 · see citing works
Cell type–specific delivery of siRNAs with aptamer-siRNA chimeras
McNamara, J. O., Andrechek, E. R., Wang, Y., Viles, K. D., Rempel, R. E., Gilboa, E., Sullenger, B. A., & Giangrande, P. H. (2006) · Nature Biotechnology · doi:10.1038/nbt1223 · Cited by 1,005 · see citing works
Mechanisms and optimization of in vivo delivery of lipophilic siRNAs
Wolfrum, C., Shi, S., Jayaprakash, K. N., Jayaraman, M., Wang, G., Pandey, R. K., Rajeev, K. G., Nakayama, T., Charrise, K., Ndungo, E. M., et al. (2007) · Nature Biotechnology · doi:10.1038/nbt1339 · Cited by 974 · see citing works
Schiffelers, R. M. (2004) · Nucleic Acids Research · doi:10.1093/nar/gnh140 · Cited by 900 · see citing works
RNAi therapeutics: Principles, prospects and challenges
Aagaard, L., & Rossi, J. J. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.03.005 · Cited by 895 · see citing works
Inhibition of respiratory viruses by nasally administered siRNA
Bitko, V., Musiyenko, A., Shulyayeva, O., & Barik, S. (2004) · Nature Medicine · doi:10.1038/nm1164 · Cited by 725 · see citing works
Urban-Klein, B., Werth, S., Abuharbeid, S., Czubayko, F., & Aigner, A. M. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302425 · Cited by 714 · see citing works
In vivo imaging of siRNA delivery and silencing in tumors
Medarova, Z., Pham, W., Farrar, C., Petkova, V., & Moore, A. (2007) · Nature Medicine · doi:10.1038/nm1486 · Cited by 697 · see citing works
Lipid-based Nanoparticles for Nucleic Acid Delivery
Li, W., & Szoka, F. C. (2007) · Pharmaceutical Research · doi:10.1007/s11095-006-9180-5 · Cited by 642 · see citing works
RNA Interference in Vitro and in Vivo Using a Novel Chitosan/siRNA Nanoparticle System
Howard, K. A., Rahbek, U. L., Liu, X., Damgaard, C. K., Glud, S. Z., Andersen, M. Ø., Hovgaard, M. B., Schmitz, A., Nyengaard, J. R., Besenbacher, F., et al. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.04.010 · Cited by 586 · see citing works
Hu‐Lieskovan, S., Heidel, J. D., Bartlett, D. W., Davis, M. E., & Triche, T. J. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0565 · Cited by 568 · see citing works
Dendrimers as multi-purpose nanodevices for oncology drug delivery and diagnostic imaging
Tomalia, D. A., Reyna, L. A., & Svenson, S. (2007) · Biochemical Society Transactions · doi:10.1042/bst0350061 · Cited by 496 · see citing works
Gene Silencing by Systemic Delivery of Synthetic siRNAs in Adult Mice
Sørensen, D. R., Leirdal, M., & Sioud, M. (2003) · Journal of Molecular Biology · doi:10.1016/s0022-2836(03)00181-5 · Cited by 469 · see citing works
Nonviral delivery of synthetic siRNAs in vivo
Akhtar, S., & Benter, I. F. (2007) · Journal of Clinical Investigation · doi:10.1172/jci33494 · Cited by 464 · see citing works
Inhibition of influenza virus production in virus-infected mice by RNA interference
Ge, Q., Filip, L., Bai, A., Nguyen, T., Eisen, H. N., & Chen, J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402486101 · Cited by 444 · see citing works
Reich, S. J., Fosnot, J., Kuroki, A. M., Tang, W., Yang, X., Maguire, A. M., Bennett, J., & Tolentino, M. J. (2003) · PubMed · Cited by 441 · see citing works
Using siRNA in prophylactic and therapeutic regimens against SARS coronavirus in Rhesus macaque
Li, B.-J., Tang, Q., Cheng, D., Qin, C., Xie, F. Y., Wei, Q., Xu, J., Liu, Y., Zheng, B.-J., Woodle, M. C., et al. (2005) · Nature Medicine · doi:10.1038/nm1280 · Cited by 433 · see citing works
PEGylated liposomes elicit an anti-PEG IgM response in a T cell-independent manner
Ishida, T., Wang, X., Shimizu, T., Nawata, K., & Kiwada, H. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.05.015 · Cited by 382 · see citing works
RNA interference: From gene silencing to gene-specific therapeutics
Leung, R. K. M., & Whittaker, P. A. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.03.004 · Cited by 382 · see citing works
Heidel, J. D., Yu, Z., Liu, J. Y.-C., Rele, S. M., Liang, Y., Zeidan, R. K., Kornbrust, D. J., & Davis, M. E. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701458104 · Cited by 382 · see citing works
siRNA relieves chronic neuropathic pain
Dorn, G. (2004) · Nucleic Acids Research · doi:10.1093/nar/gnh044 · Cited by 380 · see citing works
A Small Interfering RNA Targeting Vascular Endothelial Growth Factor as Cancer Therapeutics
Takei, Y., Kadomatsu, K., Yuzawa, Y., Matsuo, S., & Muramatsu, T. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2682 · Cited by 373 · see citing works
Efficient delivery of small interfering RNA to bone-metastatic tumors by using atelocollagen in vivo
Takeshita, F., Minakuchi, Y., Nagahara, S., Honma, K., Sasaki, H., Hirai, K., Teratani, T., Namatame, N., Yamamoto, Y., Hanai, K., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501753102 · Cited by 352 · see citing works
Liu, S. (2006) · Molecular Pharmaceutics · doi:10.1021/mp060049x · Cited by 339 · see citing works
Minakuchi, Y. (2004) · Nucleic Acids Research · doi:10.1093/nar/gnh093 · Cited by 336 · see citing works
Halder, J., Kamat, A. A., Landen, C. N., Han, L. Y., Lutgendorf, S. K., Lin, Y. G., Merritt, W. M., Jennings, N. B., Chávez‐Reyes, A., Coleman, R. L., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0021 · Cited by 297 · see citing works
Verma, U. N., Surabhi, R. M., Schmaltieg, A., Becerra, C. R., & Gaynor, R. B. (2003) · PubMed · Cited by 294 · see citing works
Li, S., & Huang, L. (2006) · Molecular Pharmaceutics · doi:10.1021/mp060039w · Cited by 282 · see citing works
Self-citationBanerjee, R., Tyagi, P., Li, S., & Huang, L. (2004) · International Journal of Cancer · doi:10.1002/ijc.20452 · Cited by 274 · see citing works
Self-citationExogenous siRNA delivery using peptide transduction domains/cell penetrating peptides
Meade, B. R., & Dowdy, S. F. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.03.004 · Cited by 274 · see citing works
Gene transfer with modified polyethylenimines
Kichler, A. (2004) · The Journal of Gene Medicine · doi:10.1002/jgm.507 · Cited by 266 · see citing works
Pillé, J.-Y., Denoyelle, C., Varet, J., Bertrand, J., Soria, J., Opolon, P., Lu, H., Pritchard, L. L., Vannier, J., Malvy, C., et al. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2004.08.029 · Cited by 264 · see citing works
Geisbert, T. W., Hensley, L. E., Kagan, E., Yu, E. Z., Geisbert, J. B., Daddario-DiCaprio, K. M., Fritz, E. A., Jahrling, P. B., McClintock, K., Phelps, J. R., et al. (2006) · The Journal of Infectious Diseases · doi:10.1086/504267 · Cited by 254 · see citing works
Kim, W. J., Christensen, L. V., Jo, S., Yockman, J. W., Jeong, J. H., Kim, Y., & Kim, S. W. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.03.022 · Cited by 251 · see citing works
Zhang, X., Shan, P., Jiang, D., Noble, P. W., Abraham, N. G., Kappas, A., & Lee, P. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312941200 · Cited by 241 · see citing works
Therapeutic potential of RNA interference against cancer
Takeshita, F., & Ochiya, T. (2006) · Cancer Science · doi:10.1111/j.1349-7006.2006.00234.x · Cited by 239 · see citing works
Chono, S., Li, S., Conwell, C. C., & Huang, L. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.07.006 · Cited by 237 · see citing works
Self-citationDelivery Vehicles for Small Interfering RNA In Vivo
de Fougerolles, A. R. (2008) · Human Gene Therapy · doi:10.1089/hum.2008.928 · Cited by 228 · see citing works
Non-viral is superior to viral gene delivery
Li, S.-D., & Huang, L. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.09.004 · Cited by 225 · see citing works
Self-citationTan, P.-H., Yang, L.-C., Hc, S., Lan, K.-C., & Cheng, J.-T. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302376 · Cited by 222 · see citing works
Akhtar, S., & Benter, I. F. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.03.010 · Cited by 219 · see citing works
Semple, S. C., Harasym, T. O., Clow, K. A., Ansell, S. M., Klimuk, S. K., & Hope, M. J. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.078113 · Cited by 211 · see citing works
Thakker, D. R., Natt, F., Hüsken, D., Maier, R., Müller, M., van der Putten, H., Hoyer, D., & Cryan, J. F. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0406214101 · Cited by 211 · see citing works
Tat-Conjugated PAMAM Dendrimers as Delivery Agents for Antisense and siRNA Oligonucleotides
Kang, H. M., DeLong, R. K., Fisher, M. H., & Juliano, R. L. (2005) · Pharmaceutical Research · doi:10.1007/s11095-005-8330-5 · Cited by 197 · see citing works
Efficient Oncogene Silencing and Metastasis Inhibition via Systemic Delivery of siRNA
Li, S., Chono, S., & Huang, L. (2008) · Molecular Therapy · doi:10.1038/mt.2008.51 · Cited by 195 · see citing works
Self-citationMaterializing the Potential of Small Interfering RNA via a Tumor-Targeting Nanodelivery System
Pirollo, K. F., Rait, A. S., Zhou, Q., Hwang, S. H., Dagata, J. A., Zon, G., Hogrefe, R. I., Palchik, G. A., & Chang, E. H. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4535 · Cited by 195 · see citing works
Tsubouchi, A., Sakakura, J., Yagi, R., Mazaki, Y., SCHAEFER, E. M., Yano, H., & Sabe, H. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200202117 · Cited by 177 · see citing works
shRNA and siRNA delivery to the brain
Pardridge, W. M. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.03.008 · Cited by 176 · see citing works
Harnessing in vivo siRNA delivery for drug discovery and therapeutic development
Xie, F. Y., Woodle, M. C., & Lu, P. Y. (2006) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03668-8 · Cited by 175 · see citing works
Chien, P.-Y., Wang, J., Carbonaro, D., Lei, S., Miller, B., Sheikh, S., Ali, S. M., Ahmad, M. U., & Ahmad, I. (2004) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700793 · Cited by 152 · see citing works
Omidi, Y., Hollins, A. J., Benboubetra, M., Drayton, R. M., Benter, I. F., & Akhtar, S. (2003) · Journal of drug targeting · doi:10.1080/10611860310001636908 · Cited by 152 · see citing works
Makimura, H., Mizuno, T. M., Mastaitis, J. W., Agami, R., & Mobbs, C. V. (2002) · BMC Neuroscience · doi:10.1186/1471-2202-3-18 · Cited by 150 · see citing works
Efficient gene silencing in metastatic tumor by siRNA formulated in surface-modified nanoparticles
Li, S., Chono, S., & Huang, L. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.11.002 · Cited by 147 · see citing works
Self-citationApplications of RNA Interference in Mammalian Systems
Martin, S. E., & Caplen, N. J. (2007) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.8.080706.092424 · Cited by 137 · see citing works
Khan, A., Benboubetra, M., Sayyed, P. Z., Ng, K. W., Fox, S. P., Beck, G., Benter, I. F., & Akhtar, S. (2004) · Journal of drug targeting · doi:10.1080/10611860400003858 · Cited by 134 · see citing works
Delivery Systems for the Direct Application of siRNAs to Induce RNA Interference (RNAi) In Vivo
Aigner, A. M. (2006) · BioMed Research International · doi:10.1155/jbb/2006/71659 · Cited by 130 · see citing works
Nakamura, H., Siddiqui, S. S., Shen, X., Malik, A. B., Pulido, J. S., Kumar, N. M., & Yue, B. Y. J. T. (2004) · PubMed · Cited by 130 · see citing works
Surface‐Modified LPD Nanoparticles for Tumor Targeting
Li, S., & Huang, L. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1348.001 · Cited by 123 · see citing works
Self-citationErbin Suppresses the MAP Kinase Pathway
Huang, Y. Z., Zang, M., Xiong, W., Luo, Z., & Mei, L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m205413200 · Cited by 120 · see citing works
Nanomedicine: Techniques, Potentials, and Ethical Implications
Ebbesen, M., & Jensen, T. G. (2006) · Journal of Biomedicine and Biotechnology · doi:10.1155/jbb/2006/51516 · Cited by 117 · see citing works
Hollins, A. J., Omidi, Y., Benter, I. F., & Akhtar, S. (2007) · Journal of drug targeting · doi:10.1080/10611860601151860 · Cited by 116 · see citing works
RNAi-Induced Gene Silencing by Local Electroporation in Targeting Brain Region
Akaneya, Y., Jiang, B., & Tsumoto, T. (2004) · Journal of Neurophysiology · doi:10.1152/jn.00161.2004 · Cited by 115 · see citing works
Sebestyén, M. G., Budker, V. G., Budker, T., Subbotin, V. M., Zhang, G., Monahan, S. D., Lewis, D. L., Wong, S. C., Hagstrom, J. E., & Wolff, J. A. (2006) · The Journal of Gene Medicine · doi:10.1002/jgm.921 · Cited by 108 · see citing works
Computer-assisted Hydrodynamic Gene Delivery
Suda, T., Suda, K., & Liu, D. (2008) · Molecular Therapy · doi:10.1038/mt.2008.66 · Cited by 107 · see citing works
Inhibition of gene expression in mice muscle by in vivo electrically mediated siRNA delivery
Golzio, M., Mazzolini, L., Moller, P., Rols, M., & Teissié, J. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302405 · Cited by 107 · see citing works
PAMAM Dendrimers as Delivery Agents for Antisense Oligonucleotides
Yoo, H., Sazani, P., & Juliano, R. L. (1999) · Pharmaceutical Research · doi:10.1023/a:1018926605871 · Cited by 104 · see citing works
Pal, A., Ahmad, A., Khan, S., Sakabe, I., Zhang, C., Kasid, U. N., & Ahmad, I. (2005) · International Journal of Oncology · doi:10.3892/ijo.26.4.1087 · Cited by 104 · see citing works
Targeted Delivery Systems of Small Interfering RNA by Systemic Administration
Kawakami, S., & Hashida, M. (2007) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.22.142 · Cited by 104 · see citing works
Non-viral siRNA delivery to the lung
Thomas, M., Lu, J. J.-Q., Chen, J., & Klibanov, A. M. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.03.003 · Cited by 95 · see citing works
Systemic siRNA delivery via hydrodynamic intravascular injection
Lewis, D. L., & Wolff, J. A. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.03.002 · Cited by 82 · see citing works
Kishida, T., Asada, H., Gojo, S., Ohashi, S., Shin‐Ya, M., Yasutomi, K., Terauchi, R., Takahashi, K. A., Kubo, T., Imanishi, J., et al. (2003) · The Journal of Gene Medicine · doi:10.1002/jgm.456 · Cited by 78 · see citing works
Noninvasive delivery of small inhibitory RNA and other reagents to pulmonary alveoli in mice
Massaro, D. J., MASSARO, G. D., & Clerch, L. B. (2004) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00067.2004 · Cited by 74 · see citing works
The Design and Exogenous Delivery of siRNA for Post-transcriptional Gene Silencing
Gilmore, I. R., Fox, S. P., Hollins, A. J., Sohail, M. F., & Akhtar, S. (2004) · Journal of drug targeting · doi:10.1080/10611860400006257 · Cited by 73 · see citing works
Shishkina, G. T., Kalinina, T., & Dygalo, N. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.08.015 · Cited by 59 · see citing works
siRNA targeted against amyloid precursor protein impairs synaptic activity in vivo
Hérard, A., Besret, L., Dubois, A., Dauguet, J., Delzescaux, T., Hantraye, P., Bonvento, G., & Moya, K. L. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.10.020 · Cited by 57 · see citing works
Development of new RNAi therapeutics.
Liu, G., Wong‐Staal, F., & Li, Q.-X. (2007) · PubMed · doi:10.14670/hh-22.211 · Cited by 51 · see citing works
Arnold, A., Tang, Y., Qian, K., Shen, L., Valencia, V., Phillips, M. I., & Zhang, Y. C. (2006) · Journal of Hypertension · doi:10.1097/01.hjh.0000254374.73241.ab · Cited by 47 · see citing works
Intracellular Delivery of Oligonucleotide Conjugates and Dendrimer Complexes
Juliano, R. L. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1348.011 · Cited by 46 · see citing works
RNA interference: potential therapeutic targets
Jana, S., Chakraborty, C., Nandi, S., & Deb, J. K. (2004) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-004-1732-1 · Cited by 45 · see citing works
Lipid-Protamine-DNA-Mediated Antigen Delivery
Vangasseri, D., Han, S., & Huang, L. (2005) · Current Drug Delivery · doi:10.2174/156720105774370168 · Cited by 31 · see citing works
Self-citationKühn, R., Streif, S., & Wurst, W. (2007) · Springer eBooks · doi:10.1007/978-3-540-35109-2_7 · Cited by 30 · see citing works
Interaction of oligonucleotide-conjugates with the dipeptide transporter system in CACO-2 cells
Moore, V., Dunnion, D. J., Brown, T. P., Irwin, W. J., & Akhtar, S. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(96)00862-3 · Cited by 13 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
siRNA vs. shRNA: Similarities and differences
Rao, D. D., Vorhies, J. S., Senzer, N. N., & Nemunaitis, J. J. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.04.004 · Cited by 658 · see citing works
Insect Molecular Biology and Biochemistry
Gilbert, L. I. (2012) · Elsevier eBooks · doi:10.1016/c2009-0-62118-8 · Cited by 429 · see citing works
Drug delivery systems: Advanced technologies potentially applicable in personalized treatments
Coelho, J. F. J., Ferreira, P. C. N., Alves, P., Cordeiro, R. A., Fonseca, A. C., Góis, J. R., & Gil, M. H. (2010) · The EPMA Journal · doi:10.1007/s13167-010-0001-x · Cited by 407 · see citing works
Current Progress in Gene Delivery Technology Based on Chemical Methods and Nano-Carriers
Jin, L., Zeng, X., Liu, M., Deng, Y., & He, N. (2014) · Theranostics · doi:10.7150/thno.6914 · Cited by 388 · see citing works
Nanoparticle Technologies for Cancer Therapy
Alexis, F., Pridgen, E. M., Langer, R., & Farokhzad, O. C. (2009) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-00477-3_2 · Cited by 372 · see citing works
Carbon nanotubes in cancer diagnosis and therapy
Ji, S.-R., Liu, C., Zhang, B., Yang, F., Xu, J., Long, J., Jin, C., Fu, D.-L., Ni, Q.-X., & Yu, X. (2010) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2010.02.004 · Cited by 340 · see citing works
Therapeutic plasmid DNA versus siRNA delivery: Common and different tasks for synthetic carriers
Scholz, C., & Wagner, E. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.11.014 · Cited by 335 · see citing works
Sheddable Ternary Nanoparticles for Tumor Acidity-Targeted siRNA Delivery
Yang, X., Du, J., Dou, S., Mao, C., Long, H., & Wang, J. (2011) · ACS Nano · doi:10.1021/nn204240b · Cited by 284 · see citing works
Uptake mechanisms of non-viral gene delivery
Xiang, S., Tong, H., Shi, Q., Fernandes, J., Jin, T., Dai, K., & Zhang, X. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.09.093 · Cited by 284 · see citing works
Drug Delivery Systems: Advanced Technologies Potentially Applicable in Personalised Treatment
Coelho, J. F. J. (2013) · Advances in predictive, preventive and personalised medicine · doi:10.1007/978-94-007-6010-3 · Cited by 223 · see citing works
Effect of surface properties on liposomal siRNA delivery
Xia, Y., Tian, J., & Chen, X. S. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.11.056 · Cited by 223 · see citing works
Ahmadzada, T., Reid, G., & McKenzie, D. R. (2018) · Biophysical Reviews · doi:10.1007/s12551-017-0392-1 · Cited by 215 · see citing works
Xu, L., & Anchordoquy, T. (2011) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22243 · Cited by 209 · see citing works
Lipid modified triblock PAMAM-based nanocarriers for siRNA drug co-delivery
Biswas, S., Deshpande, P. P., Navarro, G., Dodwadkar, N. S., & Torchilin, V. P. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.10.024 · Cited by 197 · see citing works
Targeted Polymeric Micelles for siRNA Treatment of Experimental Cancer by Intravenous Injection
Christie, R. J., Matsumoto, Y., Miyata, K., Nomoto, T., Fukushima, S., Osada, K., Halnaut, J., Pittella, F., Kim, H. J., Nishiyama, N., et al. (2012) · ACS Nano · doi:10.1021/nn300942b · Cited by 192 · see citing works
Targeted Delivery of PLK1-siRNA by ScFv Suppresses Her2 + Breast Cancer Growth and Metastasis
Yao, Y., Sun, T., Huang, S., Dou, S., Lin, L., Chen, J.-N., Ruan, J.-B., Mao, C., Yu, F., Zeng, M., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003601 · Cited by 189 · see citing works
The packaging of siRNA within the mesoporous structure of silica nanoparticles
Xu, L., Xie, Q. R., Zhang, J., Xia, W., & Gu, H. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.08.068 · Cited by 187 · see citing works
Omid Veiseh, A., Kievit, F. M., Fang, C., Mu, N., Jana, S., Leung, M. C., Mok, H., Ellenbogen, R. G., Park, J. O., & Zhang, M. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.07.016 · Cited by 183 · see citing works
Synthesis and Biological Evaluation of a Bioresponsive and Endosomolytic siRNA−Polymer Conjugate
Meyer, M., Dohmen, C., Philipp, A. B., Kiener, D., Maiwald, G., Scheu, C., Ogris, M., & Wagner, E. (2009) · Molecular Pharmaceutics · doi:10.1021/mp9000124 · Cited by 180 · see citing works
Recent trends in non‐viral vector‐mediated gene delivery
Pathak, A., Patnaik, S., & Gupta, K. C. (2009) · Biotechnology Journal · doi:10.1002/biot.200900161 · Cited by 166 · see citing works
Lipidic Systems for In Vivo siRNA Delivery
Wu, S. Y., & McMillan, N. A. J. (2009) · The AAPS Journal · doi:10.1208/s12248-009-9140-1 · Cited by 156 · see citing works
Huh, M. S., Lee, S. Y., Park, S.-J., Lee, S., Chung, H., Lee, S., Choi, Y., Oh, Y., Park, J. H., Jeong, S. Y., et al. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.02.023 · Cited by 156 · see citing works
Lipid Conjugated Oligonucleotides: A Useful Strategy for Delivery
Raouane, M., Desmaële, D., Urbinati, G., Massaad-Massade, L., & Couvreur, P. (2012) · Bioconjugate Chemistry · doi:10.1021/bc200422w · Cited by 154 · see citing works
Capacity of mesoporous bioactive glass nanoparticles to deliver therapeutic molecules
El‐Fiqi, A., Kim, T.-H., Kim, M., Eltohamy, M. R., Won, J., Lee, E., & Kim, H. (2012) · Nanoscale · doi:10.1039/c2nr31775c · Cited by 152 · see citing works
Nguyen, M. K., Jeon, O., Krebs, M. D., Schapira, D. S., & Alsberg, E. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.04.048 · Cited by 150 · see citing works
Adeli, M., Soleyman, R., Beiranvand, Z., & Madani, F. (2013) · Chemical Society Reviews · doi:10.1039/c3cs35431h · Cited by 146 · see citing works
O’Connor, R. M., Dinan, T. G., & Cryan, J. F. (2011) · Molecular Psychiatry · doi:10.1038/mp.2011.162 · Cited by 133 · see citing works
Nanotechnology and the Treatment of HIV Infection
Parboosing, R., Maguire, G. E. M., Govender, P., & Kruger, H. G. (2012) · Viruses · doi:10.3390/v4040488 · Cited by 130 · see citing works
Kumar, P., Gupta, S., & Das, B. C. (2023) · Translational Oncology · doi:10.1016/j.tranon.2023.101827 · Cited by 136 · see citing works
Nanosized Multifunctional Polyplexes for Receptor-Mediated SiRNA Delivery
Dohmen, C., Edinger, D., Fröhlich, T., Schreiner, L., Lächelt, U., Troiber, C., Rädler, J. O., Hadwiger, P., Vornlocher, H., & Wagner, E. (2012) · ACS Nano · doi:10.1021/nn300960m · Cited by 128 · see citing works
N‐Alkyl‐PEI‐Functionalized Iron Oxide Nanoclusters for Efficient siRNA Delivery
Liu, G., Xie, J., Zhang, F., Wang, Z., Luo, K., Zhu, L., Quan, Q., Niu, G., Lee, S., Ai, H., et al. (2011) · Small · doi:10.1002/smll.201100825 · Cited by 127 · see citing works
Godinho, B. M. D. C., Ogier, J. R., Darcy, R., O’Driscoll, C. M., & Cryan, J. F. (2013) · Molecular Pharmaceutics · doi:10.1021/mp3003946 · Cited by 126 · see citing works
Strategies for In Vivo Delivery of siRNAs
Higuchi, Y., Kawakami, S., & Hashida, M. (2010) · BioDrugs · doi:10.2165/11534450-000000000-00000 · Cited by 125 · see citing works
Toxicity Pathway Focused Gene Expression Profiling of PEI-Based Polymers for Pulmonary Applications
Beyerle, A., Irmler, M., Beckers, J., Kissel, T., & Stoeger, T. (2010) · Molecular Pharmaceutics · doi:10.1021/mp900278x · Cited by 123 · see citing works
Polycations and their biomedical applications
Kim, K., Chen, W. C. W., Heo, Y., & Wang, Y. (2016) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2016.05.004 · Cited by 122 · see citing works
Effective Gene Silencing by Multilayered siRNA‐Coated Gold Nanoparticles
Lee, S. K., Han, M. S., Asokan, S., & Tung, C. (2010) · Small · doi:10.1002/smll.201001314 · Cited by 117 · see citing works
Dendronized Gold Nanoparticles for siRNA Delivery
Kim, S. T., Chompoosor, A., Yeh, Y., Agasti, S. S., Solfiell, D. J., & Rotello, V. M. (2012) · Small · doi:10.1002/smll.201201141 · Cited by 116 · see citing works
Conti, D. S., Brewer, D., Grashik, J., Avasarala, S., & da Rocha, S. R. P. (2014) · Molecular Pharmaceutics · doi:10.1021/mp4006358 · Cited by 116 · see citing works
Mao, C., Du, J., Sun, T., Yao, Y., Zhang, P., Song, E., & Wang, J. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.01.006 · Cited by 115 · see citing works
Direct Translocation as Major Cellular Uptake for CADY Self-Assembling Peptide-Based Nanoparticles
Rydström, A., Deshayes, S., Konate, K., Crombez, L., Padari, K., Boukhaddaoui, H., Aldrian, G., Pooga, M., & Divita, G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025924 · Cited by 113 · see citing works
Cyclodextrin-based siRNA delivery nanocarriers: a state-of-the-art review
Chaturvedi, K., Ganguly, K., Kulkarni, A. R., Kulkarni, V. H., Nadagouda, M. N., Rudzinski, W. E., & Aminabhavi, T. M. (2011) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2011.610790 · Cited by 110 · see citing works
Tsai, Y.-J., Hu, C., Chu, C., & Imae, T. (2011) · Biomacromolecules · doi:10.1021/bm201196p · Cited by 105 · see citing works
Prolonged gene silencing by combining siRNA nanogels and photochemical internalization
Raemdonck, K., Naeye, B., Høgset, A., Demeester, J., & Smedt, S. C. D. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.04.012 · Cited by 105 · see citing works
Paul, A. M., Shi, Y., Acharya, D., Douglas, J. R., Cooley, A., Anderson, J. F., Huang, F., & Bai, F. (2014) · Journal of General Virology · doi:10.1099/vir.0.066084-0 · Cited by 102 · see citing works
Dendrimers as Carriers for siRNA Delivery and Gene Silencing: A Review
Wu, J., Huang, W., & He, Z. (2013) · The Scientific World JOURNAL · doi:10.1155/2013/630654 · Cited by 99 · see citing works
Synthetic Gene Transfer Vectors II: Back to the Future.
Behr, J. (2012) · Accounts of Chemical Research · doi:10.1021/ar200213g · Cited by 98 · see citing works
Stabilizing effect of tyrosine trimers on pDNA and siRNA polyplexes
Troiber, C., Edinger, D., Kós, P., Schreiner, L., Kläger, R., Herrmann, A., & Wagner, E. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.11.021 · Cited by 97 · see citing works
Complexation of siRNA with Dendrimer: A Molecular Modeling Approach
Vasumathi, V., & Maiti, P. K. (2010) · Macromolecules · doi:10.1021/ma1012495 · Cited by 97 · see citing works
Multi-compartmental oral delivery systems for nucleic acid therapy in the gastrointestinal tract
Kriegel, C., Attarwala, H. Z., & Amiji, M. M. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.11.003 · Cited by 93 · see citing works
Intelligent nucleic acid delivery systems based on stimuli-responsive polymers
Du, F., Wang, Y., Zhang, R., & Li, Z. (2009) · Soft Matter · doi:10.1039/b915020j · Cited by 91 · see citing works
Formulation Approaches to Short Interfering RNA and MicroRNA: Challenges and Implications
Guzman‐Villanueva, D., El-sherbiny, I. M., Herrera‐Ruiz, D., Vlassov, A. V., & Smyth, H. D. C. (2012) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23300 · Cited by 88 · see citing works
Troegeler, A., Lastrucci, C., Duval, C., Tanne, A. J., Cougoule, C., Maridonneau‐Parini, I., Neyrolles, O., & Lugo‐Villarino, G. (2014) · Immunology and Cell Biology · doi:10.1038/icb.2014.39 · Cited by 85 · see citing works
Ming, X., Alam, M. R., Fisher, M. H., Yan, Y., Chen, X. S., & Juliano, R. L. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq534 · Cited by 84 · see citing works
RNA delivery biomaterials for the treatment of genetic and rare diseases
Zhao, W., Hou, X., Vick, O. G., & Dong, Y. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119291 · Cited by 82 · see citing works
Polysaccharide-based Nanoparticles for Gene Delivery
Huh, M. S., Lee, E. J., Koo, H., Yhee, J. Y., Oh, K. S., Son, S., Lee, S., Kim, S. H., Kwon, I. C., & Kim, K. (2017) · Topics in Current Chemistry · doi:10.1007/s41061-017-0114-y · Cited by 82 · see citing works
Lipid-based vectors for siRNA delivery
Zhang, S., Zhi, D., & Huang, L. (2012) · Journal of drug targeting · doi:10.3109/1061186x.2012.719232 · Cited by 83 · see citing works
Self-citationMagnetic silica spheres with large nanopores for nucleic acid adsorption and cellular uptake
Liu, J., Wang, B., Hartono, S. B., Liu, T., Kantharidis, P., Middelberg, A. P. J., Lu, G. Q., He, L., & Qiao, S. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.10.001 · Cited by 81 · see citing works
Roy, B., Lee, E. J., Li, T., & Rampersaud, M. (2022) · Genes · doi:10.3390/genes13030425 · Cited by 81 · see citing works
Gelatin nanospheres incorporating siRNA for controlled intracellular release
Ishikawa, H., Nakamura, Y., Jo, J., & Tabata, Y. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.08.032 · Cited by 78 · see citing works
Kang, H. C., & Bae, Y. H. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.03.042 · Cited by 78 · see citing works
Recent Progress in Chemically Modified siRNAs
Gaglione, M., & Messere, A. (2010) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955710791384036 · Cited by 77 · see citing works
Bohr, A., Tsapis, N., Foged, C., Andreana, I., Yang, M., & Fattal, E. (2020) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2020.08.009 · Cited by 77 · see citing works
Hossain, S., Stanislaus, A., Chua, M. J., Tada, S., Tagawa, Y., Chowdhury, E. H., & Akaike, T. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.06.024 · Cited by 75 · see citing works
Sustained local delivery of siRNA from an injectable scaffold
Nelson, C. E., Gupta, M. K., Adolph, E. J., Shannon, J. M., Guelcher, S. A., & Duvall, C. L. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.10.033 · Cited by 73 · see citing works
Advances in siRNA delivery approaches in cancer therapy: challenges and opportunities
Isazadeh, H., Oruji, F., Shabani, S., Behroozi, J., Nasiri, H., Isazadeh, A., & Akbari, M. (2023) · Molecular Biology Reports · doi:10.1007/s11033-023-08749-y · Cited by 72 · see citing works
In Vivo Delivery Aspects of miRNA, shRNA and siRNA
Khatri, N., Rathi, M. N., Baradia, D., Trehan, S., & Misra, A. R. (2012) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v29.i6.20 · Cited by 68 · see citing works
Nucleic Acid Carriers Based on Precise Polymer Conjugates
Troiber, C., & Wagner, E. (2011) · Bioconjugate Chemistry · doi:10.1021/bc200251r · Cited by 71 · see citing works
Non-viral nanoparticles for RNA interference: Principles of design and practical guidelines
Liu, Z., Wang, S., Tapeinos, C., Torrieri, G., Känkänen, V., El‐Sayed, N., Python, A., Hirvonen, J. J., & Santos, H. A. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.05.018 · Cited by 70 · see citing works
The intracellular plasmid DNA localization of cationic reducible cholesterol-disulfide lipids
Sheng, R., Luo, T., Zhu, Y., Li, H., Sun, J., Chen, S., Sun, W., & 曹阿民 (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.01.055 · Cited by 70 · see citing works
Yu, H., Zou, Y., Jiang, L., Yin, Q., He, X., Chen, L., Zhang, Z., Gu, W., & Li, Y. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2012.12.042 · Cited by 69 · see citing works
Yhee, J. Y., Lee, S. J., Lee, S., Song, S.-Y., Min, H. S., Kang, S., Son, S., Jeong, S. Y., Kwon, I. C., Kim, S. H., et al. (2013) · Bioconjugate Chemistry · doi:10.1021/bc400226b · Cited by 68 · see citing works
Milk exosomes: A biogenic nanocarrier for small molecules and macromolecules to combat cancer
Kandimalla, R., Aqil, F., Tyagi, N., & Gupta, R. C. (2020) · American Journal of Reproductive Immunology · doi:10.1111/aji.13349 · Cited by 67 · see citing works
Ahmed, M., Deng, Z., Liu, S., Lafrenie, R. M., Kumar, A., & Narain, R. (2009) · Bioconjugate Chemistry · doi:10.1021/bc900350c · Cited by 65 · see citing works
Comparison of four different particle sizing methods for siRNA polyplex characterization
Troiber, C., Kasper, J. C., Milani, S., Scheible, M. B., Martín, I., Schaubhut, F., Hedtrich, S., Rädler, J. O., Simmel, F. C., Frieß, W., et al. (2012) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2012.08.014 · Cited by 64 · see citing works
Nanoparticle-Mediated Delivery of shRNA.VEGF-A Plasmids Regresses Corneal Neovascularization
Qazi, Y., Stagg, B. C., Singh, N., Singh, S. R., Zhang, X., Luo, L., Simonis, J. M., Kompella, U. B., & Ambati, B. K. (2012) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.11-9139 · Cited by 62 · see citing works
Combinatorial Approach to Nanoarchitectonics for Nonviral Delivery of Nucleic Acids
Molla, M. R., & Levkin, P. A. (2015) · Advanced Materials · doi:10.1002/adma.201502888 · Cited by 62 · see citing works
Li, J., Ji, Mao, Z., Wang, Zhang, W., & Su, H. (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s42440 · Cited by 59 · see citing works
Zhang, W., Müller, K., Kessel, E., Reinhard, S., He, D., Klein, P. M., Höhn, M., Rödl, W., Kempter, S., & Wagner, E. (2016) · Advanced Healthcare Materials · doi:10.1002/adhm.201600057 · Cited by 56 · see citing works
Preparation of PEGylated cationic nanoliposome-siRNA complexes for cancer therapy
Haghiralsadat, F., Amoabediny, G., Naderinezhad, S., Forouzanfar, T., Helder, M. N., & Zandieh‐Doulabi, B. (2018) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2018.1434533 · Cited by 56 · see citing works
Oroojalian, F., Rezayan, A. H., Mehrnejad, F., Nia, A. H., Shier, W. T., Abnous, K., & Ramezani, M. (2017) · Materials Science and Engineering C · doi:10.1016/j.msec.2017.05.068 · Cited by 55 · see citing works
Polymer nanocarriers for MicroRNA delivery
Kapadia, C. H., Luo, B., Dang, M. N., Irvin-Choy, N. S., Valcourt, D. M., & Day, E. S. (2019) · Journal of Applied Polymer Science · doi:10.1002/app.48651 · Cited by 54 · see citing works
Gene-based antiangiogenic applications for corneal neovascularization
Liu, S., Romano, V., Steger, B., Kaye, S. B., Hamill, K. J., & Willoughby, C. E. (2017) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2017.10.006 · Cited by 51 · see citing works
Efficient drug and gene delivery to liver fibrosis: rationale, recent advances, and perspectives
Mahdinloo, S., Kiaie, S. H., Amiri, A., Hemmati, S., Valizadeh, H., & Zakeri‐Milani, P. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.03.007 · Cited by 54 · see citing works
Zeng, S., Chen, Y., Zhou, F., Zhang, T., Fan, X., Chrzanowski, W., Gillies, M. C., & Zhu, L. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114965 · Cited by 51 · see citing works
Recent Findings Concerning PAMAM Dendrimer Conjugates with Cyclodextrins as Carriers of DNA and RNA
Arima, H., & Motoyama, K. (2009) · Sensors · doi:10.3390/s90806346 · Cited by 50 · see citing works
Ming, X., Sato, K., & Juliano, R. L. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.04.029 · Cited by 48 · see citing works
Cavalli, R., Bisazza, A., Sessa, R., Primo, L., Fenili, F., Manfredi, A., Ranucci, E., & Ferruti, P. (2010) · Biomacromolecules · doi:10.1021/bm100685t · Cited by 47 · see citing works
Paul, A., Eun, C.-J., & Song, J. M. (2014) · Polymer · doi:10.1016/j.polymer.2014.08.043 · Cited by 46 · see citing works
pH-Triggered Nanoparticle Mediated Delivery of siRNA to Liver Cells in Vitro and in Vivo
Kolli, S., Wong, S., Harbottle, R. P., Johnston, B. H., Thanou, M., & Miller, A. D. (2013) · Bioconjugate Chemistry · doi:10.1021/bc3004099 · Cited by 46 · see citing works
Carbon Nanotube-Delivered Ic9 Suicide Gene Therapy for Killing Breast Cancer Cells In Vitro
Mohseni‐Dargah, M., Akbari‐Birgani, S., Madadi, Z., Saghatchi, F., & Kaboudin, B. (2019) · Nanomedicine · doi:10.2217/nnm-2018-0342 · Cited by 46 · see citing works
Targeted si-RNA with liposomes and exosomes (extracellular vesicles): How to unlock the potential
Antimisiaris, S. G., Mourtas, S., & Παπαδιά, Κ. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.01.056 · Cited by 45 · see citing works
Zhang, Q.-Y., Ho, P. Y., Tu, M., Jilek, J. L., Chen, Q., Zeng, S., & Yu, A.-M. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.06.026 · Cited by 45 · see citing works
Delivery of siRNA to the Mouse Lung via a Functionalized Lipopolyamine
Polach, K. J., Matar, M. M., Rice, J. S., Slobodkin, G., Sparks, J., Congo, R., Rea-Ramsey, A., McClure, D., Brunhoeber, E., Krampert, M., et al. (2011) · Molecular Therapy · doi:10.1038/mt.2011.210 · Cited by 43 · see citing works
Multicomponent Synthetic Polymers with Viral-Mimetic Chemistry for Nucleic Acid Delivery
Soliman, M. E., Nasanit, R., Abulateefeh, S. R., Allen, S., Davies, M. C., Briggs, S. S., Seymour, L. W., Preece, J. A., Grabowska, A. M., Watson, S. A., et al. (2011) · Molecular Pharmaceutics · doi:10.1021/mp200108q · Cited by 43 · see citing works
Motamedi, H., Ari, M. M., Alvandi, A., & Abiri, R. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1393646 · Cited by 42 · see citing works
Xiang, G., Zhou, T., Zhang, L., Peng, F., Huang, Y., Ye, P., Lu, M., Yang, G., Gai, Y., Tan, Y., et al. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s79598 · Cited by 41 · see citing works
siRNA and Cancer Immunotherapy
Ghafouri‐Fard, S., & Ghafouri-Fard, S. (2012) · Immunotherapy · doi:10.2217/imt.12.87 · Cited by 41 · see citing works
Enzyme‐synthesized poly(amine‐co‐esters) as nonviral vectors for gene delivery
Liu, J., Jiang, Z., Zhou, J., Zhang, S., & Saltzman, W. M. (2010) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.32994 · Cited by 41 · see citing works
Kasai, H., Inoue, K., Imamura, K., Yuvienco, C., Montclare, J. K., & Yamano, S. (2019) · Journal of Nanobiotechnology · doi:10.1186/s12951-019-0444-8 · Cited by 41 · see citing works
Non-viral vectors for the mediation of RNAi
Zhang, S., Zhao, Y., Zhi, D., & Zhang, S. (2011) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2011.07.005 · Cited by 40 · see citing works
- Authors
- Gao, K., & Huang, L.
- Affiliations
- University of North Carolina at Chapel Hill (US)
- Corresponding author
- Huang, Leaf
- ORCID
- Huang, Leaf
- Venue
- Molecular Pharmaceutics
- Publisher
- American Chemical Society (ACS)
- Published
- 2008-12-30
- Volume
- 6
- Issue
- 3
- Pages
- 651-658
- ISSN
- 1543-8384 (ISSN-L)
- 1543-8392
- PMC
- PMC2692493
- OpenAlex
- W2061812894
- Cited by
- 244
- References
- 96
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 7 · 2023: 6 · 2022: 3 · 2021: 9 · 2020: 3 · 2019: 7 · 2018: 8 · 2017: 7 · 2016: 10 · 2015: 17 · 2014: 29 · 2013: 26 · 2012: 32
- FWCI
- 1.90
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Molecular Pharmaceutics (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion)
- UNC Libraries
- Funders
- National Institutes of Health
- National Cancer Institute (R01CA129835)
- National Institute of Allergy and Infectious Diseases (R56AI048851)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Physical Sciences › Materials Science › Polymers and Plastics › Dendrimers and Hyperbranched Polymers
- Keywords
- siRNA delivery, RNA interference, nanoparticle self-assembly, targeted nanoparticles, siRNA therapeutics, cancer therapy, drug target validation, functional genomics
- MeSH terms
- Animals, Humans, RNA Interference, RNA, Small Interfering, Nanotechnology, Nanoparticles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review